Skip to main content
. 2020 Sep 23;61(11):2486–2499. doi: 10.1111/epi.16701

TABLE 3.

Etiology in 116 cases of epilepsy with onset before 2 years

Etiology

Onset age

<12 mo,

n (%)

Onset age

>12 mo,

n (%)

All cases, onset age

<24 mo,

n (%)

West syndrome

n (%)[%] i

Structural a 29 (33) 10 (36) 39 (34) 14 (42)[36]
Cerebral malform b 11 (13) 5 (18) 16 (14) 4 (12)[25]
Tuberous sclerosis c 5 (5.7) 0 5 (4.3) 3 (9.1)[60]
Asphyxia 8 (9.1) 2 (7.1) 10 (8.6) 4 (12)[40]
Stroke 4 (4.5) 1 (3.6) 5 (4.3) 2 (6.1)[40]
PVL/PVH preterm 1 (1.1) 0 1 (0.9) 1 (3.0)[100]
Trauma 0 2 (7.1) 2 (1.7) 0
Metabolic disease d 9 (10) 1 (3.6) 10 (8.6) 3 (9.1)[30]
Infectious 3 (3.4) 0 3 (2.6) 1 (3.0)[33]
Immune 0 0 0 0
Underlying condition e 41 (47) 11 (39) 52 (45) 18 (55)[35]
Genetic, confirmed and no underlying condition f 14 (16) 3 (11) 17 (15) 6 (18)[35]
Monogenic epilepsy 9 (10) 3 (11) 12 (10) 2 (6.1)[17]
Chromosomal syndr. 5 (5.7) 0 5 (4.3) 4 (12)[80]
Known, total 55 (62) 14 (50) 69 (59) 24 (73)[35]
Unknown 33 (38) 14 (50) 47 (41) 9 (27)[19]
Total 88 (100) 28 (100) 116 (100) 33 (100)[28]
Genetic, confirmed with structural/metabolic 16 (18) 1 (3.6) 17 (15) 5 (15)[29]
Genetic, all confirmed 30 (34) 4 (14) 34 (29) 11 (33)[32]
Genetic, presumed g 7 (8.0) 5 (18) 12 (10) 2 (6.1)[17]
Structural/metabolic 5 (5.7) 1 (3.6) 6 (5.2) 2 (6.1)[33]
Familial syndrome 2 (2.3) 4 (14) 6 (5.2) 0
Genetic, confirmed and presum., no underlying h 16 (18) 7 (25) 23 (20) 6 (18)[26]
Genetic, all confirmed and presumed 32 (44) 9 (32) 46 (40) 13 (39)[28]
Known total, including presumed genetic 57 (65) 18 (64) 75 (65) 24 (73)[32]

[Correction added on October 10, 2020, after first online publication: the indent has been applied to "Monogenic epilepsy", "Chromosomal syndr.", "Structural/metabolic" and "Familial syndrome" since, they are subcategories.]

a

10/39 confirmed genetic cause.

b

8/16 confirmed genetic.

c

2/5 confirmed genetic.

d

7/10 confirmed genetic.

e

Structural + metabolic + infectious + immune.

f

No underlying structural or metabolic condition.

g

Cases of tuberous sclerosis (3), metabolic disease (3), BFIE (2) and GEFS+ (4), without revealed mutations.

h

Confirmed genetic without underlying structural or metabolic condition plus familial cases of BFIE and GEFS+, for comparison with other studies.

i

[%] = % of etiology.